The 20 most traded Singapore stocks that reported at least half their revenue from Greater China have averaged 22% total returns since 20 Sep, while CapitaLand China Trust, Nio, Sasseur REIT and Tianjin Pharmaceutical Da Ren Tang reported all their revenue or income from China in the last financial year.
Singapore listed stocks that booked the highest market capitalisation weighted net retail inflow in 3Q24 include Frencken, Beng Kuang Marine, AEM, UMS, MarcoPolo Marine, Yangzijiang Shipbuilding, Prime US REIT, Mermaid Maritime, Samudera Shipping, and Geo Energy Resources.
In 3Q24, retail investors net sold S$955 million worth of Singapore-listed stocks, with the bulk of the net outflow booked in September. The 5 stocks most net sold by retailers in 3Q24 included Singtel, SGX, SATS, UOB and Suntec REIT, while the 5 stocks most net bought by retailers in 3Q24 included Yangzijiang Shipbuilding, SIA, Keppel, Genting Singapore and UMS.
Global communication indices have outpaced broader global benchmarks this year, while SGX-listed Singtel, AIS TH SDR, NetLink NBN Trust, Starhub and Asian Pay TV Trust have averaged 20% total returns. Singtel has led these 5 counters this year, with a 37% total return.
STI climbed back above 3,400 on Aug 29 and closed at 3,531.17 on Sep 11. Actively traded stocks that booked the highest net institutional inflow proportionate to market cap over the 9 sessions include Seatrium, Sembcorp Industries, SGX, Suntec REIT & ComfortDelGro.
Singtel has posted a 29% total return with its average daily turnover surged 80% to S$90M, while Dyna-Mac's turnover accelerate by 132% in the 2024-to-date.
SATS booked S$28 mil net institutional inflow on 21 August, with the stock also trading 10x its usual average daily turnover. This followed SATS reporting a turnaround 1QFY25 PATMI of S$65.0 million compared to a loss of S$29.9 million in 1QFY24. Nam Cheong reported 1HFY24 NPAT of RM 635.8 million, up from RM 31.7 million in 1HFY23, primarily due to the waiver of debts. The global offshore marine group noted its business recovery is gathering pace with revenue growing 56% to RM 312.0 million for 1HFY24.
The S$506 million net institutional outflow from Singapore stock market last week was driven by Financials and Industrials. The more than 3% decline of the STI was on the back of global cross-asset repositioning that coincided with the Bank of Japan rate hike, in addition to concerns on US growth, and recent rotation from US technology stocks. Singapore’s Utilities Sector recorded S$7.1 million of net institutional inflow for the week.
Multi-Chem, SATS, SingTel, Civmec, Kim Heng, Accrelist, Great Eastern, Dyna-Mac, Venture Corp, Azeus System and Hock Lian Seng saw the most acceleration in net institutional inflow in July compared to 1H24 inflow. Pan-United, 5E Resources, Beng Kuang Marine, Azeus System, Multi-Chem and Dyna-Mac also saw average daily turnover (ADT) more than double over the 7 months compared to 2023.
The Straits Times Index (STI) added 3.7% in July, bringing the 7-month total return to 9.6%. While the STI Banks (DBS, OCBC & UOB) averaged 2.8% gains for the month, both the iEdge S-REIT Index and iEdge SG Manufacturing Index generated 5.5% total returns. The FTSE APAC Index gained 1.2% for the month, in S$ terms.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.
